Monash IVF, Virtus get a COVID-19 bump
Monash IVF and Virtus Health are set to benefit from a sharp increase in IVF volumes. as behavioural shifts stemming from the COVID-19 pandemic drive a sharp increase in the number of women seeking assisted reproductive services in Australia.
A steady rise in the age women are choosing to conceive has increased the proportion of babies born in Australia using IVF, and this trend has accelerated dramatically in the last few months, underpinning a positive outlook for the sector by broker Macquarie.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles